Awadh N, Ronco J J, Bernstein V, Gilks B, Wilcox P
Department of Medicine, University Hospital, Vancouver, Canada.
Chest. 1994 Nov;106(5):1622-4. doi: 10.1378/chest.106.5.1622.
We report a case of 63-year-old man who developed massive pulmonary hemorrhage following intravenous streptokinase for acute myocardial infarction. Pulmonary hemorrhage was diagnosed by the triad of hemoptysis, a drop in hematocrit, and a new unilateral infiltrate on chest radiograph. This diagnosis was confirmed by autopsy findings. Pulmonary hemorrhage has rarely been reported following thrombolytic therapy. We believe that pulmonary hemorrhage is a rare but a potentially life-threatening complication of thrombolytic therapy and should be considered in the differential diagnosis of pulmonary infiltrates or falling hemoglobin after thrombolytic therapy for acute myocardial infarction with no obvious site of bleeding.
我们报告一例63岁男性,在静脉注射链激酶治疗急性心肌梗死后发生大量肺出血。肺出血通过咯血、血细胞比容下降和胸部X线片上新出现的单侧浸润影三联征得以诊断。尸检结果证实了这一诊断。溶栓治疗后发生肺出血的情况鲜有报道。我们认为,肺出血是溶栓治疗罕见但可能危及生命的并发症,在对急性心肌梗死溶栓治疗后出现肺部浸润影或血红蛋白下降且无明显出血部位的情况进行鉴别诊断时应予以考虑。